Kukreja v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided November 14, 2017·No. 14-104·Published

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-104V (to be Published)

************************* Special Master Corcoran ANIL JOHN KUKREJA, and MICHAL * KUKREJA, parents of D.K., a minor, * * Filed: September 5, 2017 Petitioners, * v. * Attorney’s Fees and Costs; * Pro Se Claimants; Undisclosed SECRETARY OF HEALTH * Representation of Claimants AND HUMAN SERVICES, * * Respondent. * * *************************

Lisa A. Roquemore, Law Office of Lisa A. Roquemore, Rancho Santa Margarita, CA for Petitioners.

Claudia B. Gangi, U.S. Dep’t of Justice, Washington, DC for Respondent.

DECISION GRANTING IN PART MOTION FOR ATTORNEY’S FEES AND COSTS1

On February 6, 2014, Anil John and Michal Kukreja filed a petition on behalf of their son, D.K., seeking compensation under the National Vaccine Injury Compensation Program (“Vaccine Program”).2 Petitioners allege that D.K. suffered from myoclonic seizures as a result of his February 7, 2011, receipt of the influenza (“flu”) and/or Hepatitis A vaccines. After nearly three years of filing medical records and expert reports in preparation for a hearing scheduled in October

1 This decision will be posted on the United States Court of Federal Claims’s website, in accordance with the E- Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the ruling will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will be available to the public in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). 2016, the parties filed a stipulation for damages, for the sum total of $15,000.00. See Stipulation, dated Jan. 24, 2017 (ECF No. 54). Shortly thereafter, I issued a decision on damages consistent with the stipulation. See Decision, dated Jan. 27, 2017 (ECF No. 56).

Petitioners have now filed a motion for final attorney’s fees and costs, requesting a combined amount of $112,791.60 ($80,410.20 in attorney’s fees, $23,217.36 in costs expended by Petitioners’ counsel, and $9,164.04 in costs for Petitioners’ personal litigation costs). Motion for Attorney’s Fees and Costs, dated July 12, 2017 (ECF No. 61) (“Fees App.”). Respondent reacted on July 25, 2017, stating that he is satisfied that the statutory requirements for an award of attorney’s fees and costs are met in this case, but deferring to my discretion the determination of the amount to be awarded. ECF No. 63. For the reasons stated below, I hereby GRANT IN PART Petitioners’ request for fees and costs.

Background

This case was initiated by the Kukrejas in February 2014 as pro se Petitioners. I originally set a deadline that all medical records and a statement of completion should be filed by May 26, 2014, but that deadline was extended numerous times to assist the Kukrejas with document gathering. The statement of completion was filed on November 17, 2014, followed shortly by Respondent’s Rule 4(c) Report. Thereafter, I held a status conference, encouraging Petitioners to seek counsel, and also setting a deadline for Petitioners to file an expert report. See Scheduling Order dated, Jan. 13, 2015 (ECF No. 22). At this time, Petitioners stated that they had retained an attorney, and I accordingly instructed that attorney to promptly enter an appearance in the case. Id. Petitioners’ current counsel, Lisa A. Roquemore, Esq., did so on February 2, 2015. (ECF No. 23).

Despite the appearance that the Kukrejas were pro se through February 2015, a review of Ms. Roquemore’s billing invoices submitted with the present fees motion reveals that she had actually been advising the Kukrejas since August 2013—over six months before they filed their case, and a year and a half before she entered an appearance in the case. See generally Fees App., Exhibit 2. The billing invoices demonstrate that during this time, Ms. Roquemore was reviewing all the filings of the court (in paper form, since she was not yet the attorney of record and therefore lacked direct electronic access to the docket). In this eighteen-month period, Ms. Roquemore billed 60.6 hours to the matter, for a total of $16,646.00 – more than the settlement sum.

After Ms. Roquemore entered her appearance, the case proceeded on a litigation track. The parties subsequently filed several expert reports, and then an entitlement hearing was scheduled for October 2016. However, the case never went to hearing, as a 15-week order was issued on September 30, 2016, at the request of the parties, in order to provide them the opportunity to settle the matter. As noted above, those settlement discussions were successful, although they produced a relatively modest award in comparison to the work the parties put into the case. The sole remaining issue for resolution is what fees and costs to award counsel.

2 ANALYSIS

The Vaccine Act permits an award of reasonable attorney’s fees and costs to successful litigants, and therefore some fees and costs award herein is warranted. Section 15(e). Fees in Vaccine Program cases are generally calculated pursuant to the “lodestar method,” whereby the special master determines if the attorney’s hourly rate and time devoted to the matter are reasonable. Avera v. Sec'y of Health & Human Servs., 515 F.3d 1343, 1347-48 (Fed. Cir. 2008)

Though Respondent has not lodged an objection to the sum requested, special masters have discretion to determine the reasonableness of a fees award sua sponte. Sabella v. Sec’y of Health & Human Servs., 96 Fed. Cl. 201, 208-09 (2009); Perreira v. Sec’y of Health & Human Servs., 27 Fed. Cl. 29, 34 (1992), aff’d, 33 F.3d 1375 (Fed. Cir. 1994). Here, I find adjustment to the requested amount is warranted, for the reasons stated below.

I. Hourly Rates

An attorney’s reasonable hourly rate is determined by the “forum rule,” which applies the hourly rate paid to similarly qualified attorneys in the forum in which the relevant court sits (Washington, DC, for Vaccine Act cases), except where an attorney’s work was not performed in the forum and there is a substantial difference in rates. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1348 (Fed. Cir. 2008). The hourly rate ranges for attorneys of different levels of experience who are entitled to the forum rate in Vaccine Program cases were recently set forth in McCulloch v. Sec’y of Health & Human Servs., No. 09-293V, 2015 WL 5634323, at *19 (Fed. Cl. Spec. Mstr. Sept.

Free access — add to your briefcase to read the full text and ask questions with AI

Kukreja v. Secretary of Health and Human Services, (uscfc 2017).

Kukreja v. Secretary of Health and Human Services (Kukreja v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related